Orexigen diet pill recommended for approval in Europe

December 19, 2014 12:49 PM

11 0

LONDON (Reuters) - A new diet pill from Orexigen Therapeutics Inc has been recommended for approval in Europe, the European Medicines Agency (EMA) said on Friday.

The drug, known as Contrave in the United States, will be marketed as Mysimba in Europe.

Read more

To category page

Loading...